Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Elizabeth A Abrams

Datos Biográficos

ID7990402
NOMBREElizabeth A Abrams
NOMBRESElizabeth A
APELLIDOAbrams
FIRMAABRAMS E A
AFILIACIONESThe Ohio State University College of Medicine
ORCID0000-0003-4817-3448
VERIFICADOSí
TOTAL DE OBRAS3
TOTAL DE CITAS0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0
  • Reducing Buprenorphine Misinformation as a Strategy to Improve Adoption in Primary Care

    Open Access•Sean Bogart, Cheyenne Fenstemaker et al.•ARTICLE•Substance Use & Misuse•2026

    BACKGROUND: Buprenorphine is a highly effective medication for opioid use disorder, but it has not been widely implemented in primary care. Negative attitudes toward the medication are a well-known prescribing barrier. Health misinformation, a phenomenon which negatively informs attitudes and subsequent behavior, has been associated with lower willingness to treat OUD. Attitudinal barriers to buprenorphine prescribing may be due in part to misinf…

  • Primary care professionals’ perspectives on tailoring buprenorphine training for rural practice

    Open Access•Cheyenne Fenstemaker, Elizabeth A Abrams et al.•ARTICLE•The Journal of Rural Health•2024

    PURPOSE: Buprenorphine is a highly effective medication for opioid use disorder (OUD) that remains substantially underutilized by primary care professionals (PCPs). This is particularly true in rural communities, which have fewer prescribers and significant access disparities. The Drug Enforcement Administration removed the X-waiver requirement in December 2022, yet many rural clinicians still report barriers to prescribing buprenorphine. In this…

  • So hurt and broken’

    Open Access•Katherine G Merrill, Jacquelyn C Campbell et al.•ARTICLE•Global Public Health•2021

    Emerging data show associations between violence victimisation and negative HIV outcomes among youth in sub-Saharan Africa. We conducted in-depth interviews with adolescents and young adults living with HIV (aged 15-24 years) in Ndola, Zambia, to better understand this relationship. We purposively selected 41 youth (24 females, 17 males) with varied experiences of violence and virologic results. Analysis used thematic coding. Two-thirds of partic…

Sin obras prominentes en esta página.

  • So hurt and broken’

    Open Access•Katherine G Merrill, Jacquelyn C Campbell et al.•ARTICLE•Global Public Health•2021

    Emerging data show associations between violence victimisation and negative HIV outcomes among youth in sub-Saharan Africa. We conducted in-depth interviews with adolescents and young adults living with HIV (aged 15-24 years) in Ndola, Zambia, to better understand this relationship. We purposively selected 41 youth (24 females, 17 males) with varied experiences of violence and virologic results. Analysis used thematic coding. Two-thirds of partic…

  • Primary care professionals’ perspectives on tailoring buprenorphine training for rural practice

    Open Access•Cheyenne Fenstemaker, Elizabeth A Abrams et al.•ARTICLE•The Journal of Rural Health•2024

    PURPOSE: Buprenorphine is a highly effective medication for opioid use disorder (OUD) that remains substantially underutilized by primary care professionals (PCPs). This is particularly true in rural communities, which have fewer prescribers and significant access disparities. The Drug Enforcement Administration removed the X-waiver requirement in December 2022, yet many rural clinicians still report barriers to prescribing buprenorphine. In this…

  • Reducing Buprenorphine Misinformation as a Strategy to Improve Adoption in Primary Care

    Open Access•Sean Bogart, Cheyenne Fenstemaker et al.•ARTICLE•Substance Use & Misuse•2026

    BACKGROUND: Buprenorphine is a highly effective medication for opioid use disorder, but it has not been widely implemented in primary care. Negative attitudes toward the medication are a well-known prescribing barrier. Health misinformation, a phenomenon which negatively informs attitudes and subsequent behavior, has been associated with lower willingness to treat OUD. Attitudinal barriers to buprenorphine prescribing may be due in part to misinf…

Buprenorphine (2 obras) · Medicine (2 obras) · Opioid use disorder (2 obras) · Primary care (2 obras) · Psychological intervention (2 obras) · Qualitative research (2 obras) · Thematic analysis (2 obras) · Adolescent Sexual and Reproductive Health (1 obras) · Attendance (1 obras) · Clinical Psychology (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae